Cargando…
Super Enhancer-Regulated LINC00094 (SERLOC) Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma
SIMPLE SUMMARY: Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer, and its incidence is increasing worldwide. The prognosis of the metastatic disease is poor, and there are no established biomarkers for the assessment of metastasis risk or specific therapeutic target...
Autores principales: | Piipponen, Minna, Riihilä, Pilvi, Knuutila, Jaakko S., Kallajoki, Markku, Kähäri, Veli-Matti, Nissinen, Liisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406669/ https://www.ncbi.nlm.nih.gov/pubmed/36010973 http://dx.doi.org/10.3390/cancers14163980 |
Ejemplares similares
-
The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma
por: Piipponen, Minna, et al.
Publicado: (2021) -
Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study
por: KNUUTILA, Jaakko S., et al.
Publicado: (2020) -
Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma
por: Rahmati Nezhad, Pegah, et al.
Publicado: (2022) -
Complement System in Cutaneous Squamous Cell Carcinoma
por: Riihilä, Pilvi, et al.
Publicado: (2019) -
Identification of metastatic primary cutaneous squamous cell carcinoma utilizing artificial intelligence analysis of whole slide images
por: Knuutila, Jaakko S., et al.
Publicado: (2022)